| Literature DB >> 26569272 |
Masanari Watanabe1, Hisashi Noma2, Jun Kurai3, Hiroyuki Sano4, Hiroya Kitano5, Rumiko Saito6, Yutaka Kimura7, Setsuya Aiba8, Mitsuo Oshimura9, Eiji Shimizu10.
Abstract
This study aimed to investigate the effects of particulate matter (PM) on pulmonary function in schoolchildren, as well as the relationships of these effects with interleukin-8. Morning peak expiratory flow (PEF) was measured daily in 399 children during April-May 2012, and in 384 of these children during March-May 2013. PEF's association with the daily levels of suspended particulate matter (SPM) and PM < 2.5 mm (PM2.5) was estimated using a linear mixed model. Interleukin-8 promoter activity was assessed in THP-G8 cells stimulated by fallen PM collected at Tottori University Hospital during four periods (two in 2012 and two in 2013). An increase of 14.0 mg/m³ in SPM led to PEF changes of -2.16 L/min in 2012 and -0.81 L/min in 2013, respectively. An increment of 10.7 mg/m³ in PM2.5 was associated with PEF changes of -2.58 L/min in 2012 and -0.55 L/min in 2013, respectively. These associations were only significant in 2012. Interleukin-8 promoter activity was significantly higher in both periods of 2012 than in 2013. There was a significant association between pulmonary function in schoolchildren and daily levels of SPM and PM2.5, but this association may differ depending on the PM's ability to elicit interleukin-8 production.Entities:
Keywords: PM2.5; interlukin-8; peak expiratory flow; schoolchildren; suspended particle matter
Mesh:
Substances:
Year: 2015 PMID: 26569272 PMCID: PMC4661643 DOI: 10.3390/ijerph121114229
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flow chart showing the recruitment of the children in the study.
Characteristics of the schoolchildren included in the study.
| 2012 | 2013 | |
|---|---|---|
| 399 | 384 | |
| Boy/Girl | 205/194 | 194/190 |
| 132.3 ± 5.9 | 137.7 ± 7.0 | |
| Boy | 132.2 ± 5.5 | 136.9 ± 6.3 |
| Girl | 132.4 ± 6.4 | 138.5 ± 7.7 |
| 29.5 ± 5.8 | 32.4 ± 6.6 | |
| Boy | 29.6 ± 6.2 | 32.3 ± 6.8 |
| Girl | 29.3 ± 5.4 | 32.6 ± 6.4 |
| Asthma | 38 | 45 |
| Allergic rhinitis | 78 | 74 |
| Allergic conjunctivitis | 8 | 15 |
| Atopic dermatitis | 44 | 36 |
| Food allergy | 19 | 20 |
Data are shown as the mean ± standard deviation.
Associations of PEF values with interquartile increases in SPM and PM2.5 in linear mixed-effects models for the 2012 and 2013 surveys.
| Year | Exposure Metric | IQR | All Children | ||
|---|---|---|---|---|---|
| Change in PEF Value (L/min) | 95%CI | ||||
| 2012 | SPM | 14.0 μg/m3 | −2.16 | −2.88, −1.43 | <0.0001 |
| PM2.5 | 10.7 μg/m3 | −2.58 | −3.59, −1.57 | <0.0001 | |
| 2013 | SPM | 14.0 μg/m3 | −0.81 | −1.68, 0.06 | 0.068 |
| PM2.5 | 10.7 μg/m3 | −0.55 | −1.30, 0.19 | 0.146 | |
| 2012 | SPM | 14.0 μg/m3 | −2.06 | −2.81, −1.30 | <0.0001 |
| PM2.5 | 10.7 μg/m3 | −2.46 | −3.51, −1.41 | <0.0001 | |
| 2013 | SPM | 14.0 μg/m3 | −0.44 | −1.37, 0.47 | 0.337 |
| PM2.5 | 10.7 μg/m3 | −0.29 | −1.07, 0.49 | 0.464 | |
| 2012 | SPM | 14.0 μg/m3 | −3.11 | −5.70, −0.54 | 0.018 |
| PM2.5 | 10.7 μg/m3 | −3.69 | −7.28, −0.10 | 0.044 | |
| 2013 | SPM | 14.0 μg/m3 | −3.41 | −6.11, −0.70 | 0.014 |
| PM2.5 | 10.7 μg/m3 | −2.42 | −4.70, −0.13 | 0.039 | |
IQR: interquartile range; CI: confidence interval; PEF: peak expiratory flow; SPM: suspended particulate matter; PM2.5: particulate matter smaller than 2.5 μm in diameter.
Figure 2The associations of daily average peak expiratory flow (PEF) values and daily levels of suspended particulate matter (SPM) and particulate matter smaller than 2.5 μm in diameter (PM2.5) in the 2012 and 2013 surveys.
Figure 3Interleukin-8 transcriptional activity measured using an interleukin -8 luciferase assay in a stable THP-1-derived interleukin-8 reporter cell line. Interleukin-8 transcriptional activity is based on normalized stable luciferase orange luciferase activity (nSLO-LA), which was calculated as stable luciferase orange luciferase activity divided by stable luciferase red luciferase activity. Cells were treated with solvent only (n = 6, negative control), lipopolysaccharide (LPS) (n = 6, 100 ng/mL, positive control), or particulate matter collected on: April 7–20, 2012 (n = 6, 1 mg/mL); April 26–May 10, 2012 (n = 6, 1 mg/mL); April 8–22, 2013 (n = 6, 1 mg/mL); and April 30–May 13, 2013 (n = 6, 1 mg/mL). * p < 0.0001 for the comparison with particulate matter collected during April 7–20, 2012. § p < 0.005 for the comparison with PM collected during April 26–May 10, 2012.